Pnina Fishman
Founder bij CAN-FITE BIOPHARMA LTD.
Vermogen: 2 013 $ op 31-03-2024
Profiel
Pnina Fishman is the founder of Can-Fite BioPharma Ltd., which was founded in 1994.
She currently holds the position of Executive Chairman & Chief Scientific Officer at Can-Fite BioPharma Ltd.
Dr. Fishman is also currently serving as a Director at Eyefite Ltd., Consulting F.D.
International Marketing & Engingeering Ltd., Ultratrend Ltd., and Fd Consulting Ltd.
In the past, she served as the Chief Executive Officer at Mor Research Applications Ltd.
and as the Chairman at OphthaliX, Inc. from 2013 to 2014.
Dr. Fishman also held the title of Professor at Rabin Medical Center Beilinson.
She obtained a doctorate degree from Bar-Ilan University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
CAN-FITE BIOPHARMA LTD.
0.02% | 28-03-2024 | 263 433 ( 0.02% ) | 2 013 $ | 31-03-2024 |
Actieve functies van Pnina Fishman
| Bedrijven | Functie | Begin |
|---|---|---|
| CAN-FITE BIOPHARMA LTD. | Founder | 11-09-1994 |
| Consulting F.D. International Marketing & Engingeering Ltd. | Director/Board Member | - |
Eyefite Ltd.
 Eyefite Ltd. BiotechnologyHealth Technology Eyefite Ltd. provides ophthalmology research and develops pharmaceutical products. The company is headquartered in Ramat Gan, Israel. | Director/Board Member | - |
| Ultratrend Ltd. | Director/Board Member | - |
| Fd Consulting Ltd. | Director/Board Member | - |
Eerdere bekende functies van Pnina Fishman
| Bedrijven | Functie | Einde |
|---|---|---|
Rabin Medical Center Beilinson
 Rabin Medical Center Beilinson Hospital/Nursing ManagementHealth Services Rabin Medical Center Beilinson provides hospital medical services. The private company is based in Petach Tikva, Israel. The CEO of the Israeli company is Eyran Halpern. | Corporate Officer/Principal | - |
| Mor Research Applications Ltd. | Chief Executive Officer | - |
OphthaliX, Inc.
 OphthaliX, Inc. Pharmaceuticals: MajorHealth Technology OphthaliX, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic products for ophthalmic disorders. Its portfolio includes CF101 oral drug that intends to treat glaucoma and uveitis. The company was founded by Ilan Cohn on December 10, 1999 and is headquartered in Petach Tikva, Israel. | Chief Executive Officer | - |
Opleiding van Pnina Fishman
| Bar-Ilan University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CAN-FITE BIOPHARMA LTD. | Health Technology |
| Bedrijven in privébezit | 7 |
|---|---|
OphthaliX, Inc.
OphthaliX, Inc. Pharmaceuticals: MajorHealth Technology OphthaliX, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic products for ophthalmic disorders. Its portfolio includes CF101 oral drug that intends to treat glaucoma and uveitis. The company was founded by Ilan Cohn on December 10, 1999 and is headquartered in Petach Tikva, Israel. | Health Technology |
| Mor Research Applications Ltd. | |
Rabin Medical Center Beilinson
Rabin Medical Center Beilinson Hospital/Nursing ManagementHealth Services Rabin Medical Center Beilinson provides hospital medical services. The private company is based in Petach Tikva, Israel. The CEO of the Israeli company is Eyran Halpern. | Health Services |
Eyefite Ltd.
Eyefite Ltd. BiotechnologyHealth Technology Eyefite Ltd. provides ophthalmology research and develops pharmaceutical products. The company is headquartered in Ramat Gan, Israel. | Health Technology |
| Consulting F.D. International Marketing & Engingeering Ltd. | |
| Ultratrend Ltd. | |
| Fd Consulting Ltd. |
